Giri Yam R, Peteru Sachidanand R
J Psychiatr Pract. 2019 Mar;25(2):139-145. doi: 10.1097/PRA.0000000000000367.
Impulse-control problems such as gambling, increased spending, hypersexuality, and compulsive eating are thought to be influenced by temperamental, genetic, and physiological risk factors. In addition, dopamine receptor agonists have been implicated in some cases. It is postulated that aripiprazole may cause impulse-control problems because it can produce a hyperdopaminergic state in the mesolimbic pathway (reward system) through its predominant action on dopamine D3 receptors. We present the case of a patient with bipolar disorder and previous gambling behavior, in whom the gambling behavior escalated with the introduction of aripiprazole and its upward titration. The patient's gambling problems were alleviated with a decrease in aripiprazole dosage. Clinicians should be vigilant for possible gambling and other impulse-control behaviors in patients taking aripiprazole. Our literature review suggests cariprazine and brexpiprazole, which have mechanisms of action similar to that of aripiprazole, may also be associated with possible risks of impulse-control problems and pathologic gambling.
冲动控制问题,如赌博、消费增加、性欲亢进和强迫性进食,被认为受到气质、遗传和生理风险因素的影响。此外,多巴胺受体激动剂在某些情况下也与之有关。据推测,阿立哌唑可能会导致冲动控制问题,因为它可通过对多巴胺D3受体的主要作用在中脑边缘通路(奖赏系统)产生高多巴胺能状态。我们报告一例患有双相情感障碍且既往有赌博行为的患者,在使用阿立哌唑并向上滴定剂量后,其赌博行为升级。随着阿立哌唑剂量的减少,患者的赌博问题得到缓解。临床医生应对服用阿立哌唑的患者可能出现的赌博及其他冲动控制行为保持警惕。我们的文献综述表明,作用机制与阿立哌唑相似的卡利拉嗪和布雷斯哌唑,也可能与冲动控制问题和病理性赌博的潜在风险有关。